The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward

Por Kieran, Mark W., Kalluri, Raghu, Cho, Yoon-Jae
Publicado em 2012

Could α5-GABA-A receptor activation be used as a target for managing medulloblastomas?

Por Sengupta, Soma, Weeraratne, Shyamal D, Cho, Yoon-Jae, L Pomeroy, Scott
Publicado no CNS Oncol (2014)

Thyroid fine-needle aspiration biopsy positively correlates with increased diagnosis of thyroid cancer in South Korean patients

Por Cho, Yoon Jae, Kim, Do Young, Park, Eun-Cheol, Han, Kyu-Tae
Publicado no BMC Cancer (2017)

Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences

Por Balaj, Leonora, Lessard, Ryan, Dai, Lixin, Cho, Yoon-Jae, Pomeroy, Scott L., Breakefield, Xandra O., Skog, Johan
Publicado em 2011

Dasatinib suppression of medulloblastoma survival and migration is markedly enhanced by combining treatment with the aurora kinase inhibitor AT9283

Por Petersen, William, Liu, Jingbo, Yuan, Liangping, Zhang, Hongying, Schneiderjan, Matthew, Cho, Yoon-Jae, MacDonald, Tobey J.
Publicado em 2014

miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma

Por Weeraratne, Shyamal D., Amani, Vladimir, Neiss, Adrianne, Teider, Natalia, Scott, Deborah K., Pomeroy, Scott L., Cho, Yoon-Jae
Publicado em 2011

PDTM-36. FUNCTIONAL GENOMIC ANALYSIS OF MYC-AMPLIFIED MEDULLOBLASTOMA NOMINATES THE TGFB PATHWAY AS A CLINICALLY VIABLE TARGET

Por Henderson, Jacob, Cho, Hyeyoung, Davare, Monika, Tsherniak, Aviad, Cowley, Glenn, Weir, Barbara, Hahn, William C, Cho, Yoon-Jae
Publicado no Neuro Oncol (2017)

EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma

Por McKinney, Nicole, Yuan, Liangping, Zhang, Hongying, Liu, Jingbo, Cho, Yoon-Jae, Rushing, Elisabeth, Schniederjan, Matthew, MacDonald, Tobey J.
Publicado no J Neurooncol (2014)

Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration

Por Yuan, Liangping, Zhang, Hongying, Liu, Jingbo, Rubin, Joshua B, Cho, Yoon-Jae, Shu, Hui Kuo, Schniederjan, Matthew, MacDonald, Tobey J
Publicado em 2013

MB-11 IMPACT OF MOLECULAR SUB-TYPE AND CRANIOSPINAL IRRADIATION (CSI) DOSE ON RELAPSE OF MEDULLOBLASTOMA

Por Wang, Ange, Partap, Sonia, Yeom, Kristen, Martinez, Mesha, Vogel, Hannes, Donaldson, Sarah, Fisher, Paul, Perreault, Sebastien, Cho, Yoon-Jae, Gibbs, Iris
Publicado no Neuro Oncol (2015)

PDTM-34. COMBINED BET BROMODOMAIN AND CDK2 INHIBITION IN MYC-DRIVEN MEDULLOBLASTOMA

Por Bolin, Sara, Borgenvik, Anna, Persson, Camilla, Sundström, Anders, Qi, Jun, Bradner, James, Weiss, William, Cho, Yoon-Jae, Weishaupt, Holger, Swartling, Fredrik
Publicado no Neuro Oncol (2017)

Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: A severe form of human achondroplasia

Por Guo, Changsheng, Degnin, Catherine R., Laederich, Melanie B., Lunstrum, Gregory P., Holden, Paul, Bihlmaier, Jeanie, Krakow, Deborah, Cho, Yoon-Jae, Horton, William A.
Publicado em 2008

Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma

Por Teider, Natalia, Scott, Deborah K., Neiss, Adrianne, Weeraratne, S. Dilhan, Amani, Vladimir M., Wang, Yifei, Marquez, Victor E., Cho, Yoon-Jae, Pomeroy, Scott L.
Publicado em 2010

HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES HDAC INHIBITORS AS CANDIDATE THERAPEUTICS FOR MYC-DRIVEN MEDULLOBLASTOMA

Por Wechsler-Reya, Robert J., Pei, Yanxin, Liu, Kun-Wei, Wang, Jun, Esparza, Lourdes A., Maier, Donna L., Li, Xiao-Nan, Cho, Yoon-Jae
Publicado em 2014

MB-01 NOTCH1 PROMOTES MYC MEDULLOBLASTOMA METASTASIS, INITIATION AND MAINTENANCE

Por Kahn, Suzana, Nitta, Ryan, Wang, Kevin, Gholamin, Sharareh, Azad, Tej, Zhang, Michael, Cho, Yoon-Jae, Taylor, Michael, Mitra, Siddhartha, Weissman, Irving, Cheshier, Samuel
Publicado no Neuro Oncol (2015)

MB-19 MEDULLOBLASTOMA SUBTYPES SPECIFY INTER-TUMORAL VASCULAR BLOOD BRAIN BARRIER HETEROGENEITY

Por Phoenix, Timothy, Patmore, Deanna, Boop, Scott, Jacus, Megan, Patel, Yogesh, Goumnerova, Lilian, Perreault, Sebastien, Wadhwa, Elizabeth, Cho, Yoon-Jae, Stewart, Clinton, Gilbertson, Richard
Publicado no Neuro Oncol (2015)

IMPS-26 HARNESSING THE MYELOID CHECKPOINT CD47-SIRPa AXIS AGAINST ADULT AND PEDIATRIC MALIGNANT BRAIN TUMORS: A NOVEL IMMUNOTHERAPEUTIC MODALITY

Por Gholamin, Sharareh, Mitra, Siddhartha, Esparza, Rogelio, Liu, Jie, Feroze, Abdullah, Cho, Yoon Jae, Zhang, Michael, Vogel, Hannes, Edwards, Michael, Weissman, Irving, Cheshier, Samuel
Publicado no Neuro Oncol (2015)

Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5

Por Mora-Blanco, E. Lorena, Mishina, Yuji, Tillman, Erik J., Cho, Yoon-Jae, Thom, Christopher S., Pomeroy, Scott L., Shao, Wenlin, Roberts, Charles W.M.
Publicado no Oncogene (2013)

mSWI/SNF (BAF) Complexes Facilitate Decatentation of DNA by Topoisomerase IIα

Por Dykhuizen, Emily C., Hargreaves, Diana C., Miller, Erik, Cui, Kairong, Korshunov, Andrey, Kool, Marcel, Pfister, Stefan, Cho, Yoon-Jae, Zhao, Keji, Crabtree, Gerald R.
Publicado em 2013

Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment

Por Ullrich, Nicole J., Kieran, Mark W., Miller, David T., Gordon, Leslie B., Cho, Yoon-Jae, Silvera, V. Michelle, Giobbie-Hurder, Anita, Neuberg, Donna, Kleinman, Monica E.
Publicado em 2013